English
 
Help Privacy Policy Disclaimer
  Advanced SearchBrowse

Item

ITEM ACTIONSEXPORT

Released

Meeting Abstract

Glyco- and Fc engineering of IgA antibodies for cancer immunotherapy improved pharmacokinetics & myeloid effector cell engagement

MPS-Authors
/persons/resource/persons121655

Möginger,  U.
Daniel Kolarich, Biomolekulare Systeme, Max Planck Institute of Colloids and Interfaces, Max Planck Society;

/persons/resource/persons121498

Kolarich,  D.
Daniel Kolarich, Biomolekulare Systeme, Max Planck Institute of Colloids and Interfaces, Max Planck Society;

External Resource
No external resources are shared
Fulltext (public)
There are no public fulltexts stored in PuRe
Supplementary Material (public)
There is no public supplementary material available
Citation

Kretschmer, A., Lohse, S., Meyer, S., Meulenbroek, L., Jansen, J., Möginger, U., et al. (2016). Glyco- and Fc engineering of IgA antibodies for cancer immunotherapy improved pharmacokinetics & myeloid effector cell engagement. Oncology Research and Treatment, 39(Suppl. 3): P276, 83-84.


Cite as: http://hdl.handle.net/11858/00-001M-0000-002C-0994-7
Abstract
There is no abstract available